Building Wealth For Those Who Follow!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ARIA moving after hours.
Nice board Bob. Following it now. You're making very good calls!
Great pick sheff!
Quality Of Evidence Used By FDA To Approve New Drugs Varies Widely..
http://www.forbes.com/sites/edsilverman/2014/01/21/quality-of-evidence-used-by-fda-to-approve-new-drugs-varies-widely/?partner=yahootix
Is anyone else having issues getting their ihub mail to open on their mobile device ?
I'm in with you sheff! MSTX
That's very good news sheff!!!
Nonetheless, someone is the proud owner of 35 shares at 1.69$ :)
Like what I'm seeing here .. Taking a position :)
RGDX bought on this dip.
Beautiful job musthavemusic !!
CBMX moving:) Let's see if it holds.
CBMX looking good pre market.
I'm also expecting a big week! Hopefully an exciting year Combimatrix:)
Sheff,
Do you think CBMX is on the right track to get back to 5 year highs or what's a reasonable target? Looks like they have a 15$ target on it now if I'm not mistaking .
SQNM european patent out - SA article on CBMX and SQNM
A new marketing brochure has been found on the internet indicating some potential new tests:
This brochure has a couple of new carrier tests that have been branded under the Sequenom "HerediT" brand. HerediTSMA was developed by Quest Diagnostics and the others developed by Mt Sinai Genetic Testing Laboratory. See back cover of brochure for details. What makes this intriguing is that the FDA rules for LDTs require that only the lab that develops the test can process them. Both Mt Sinai and Quest have been using massARRAY for RUO for quite some time and it appears they are now ready to buy the IMPACT Dx platforms to process patient carrier screens for Spinal Muscular Atrophy, Fragile X and Ashkenazi Jewish panel. These 3 carrier screens have not been publicly announced which likely means they are awaiting FDA approval.
The brochure also references a new product branded NextView. This appears to be an amniotic fluid analysis for positive outcomes of the MaterniT21 Plus diagnostic screen. This test name has been trademarked by Sequenom though the test would be done by CombiMatrix. This is also likely going to be announced soon as the company will likely want to include it in their presentation next week. This could provide a significant increase in microarray tests done by CombiMatrix. In their last 10Q they disclose around 1,100 tests done. Sequenom has disclosed that a little over 2% of their MaterniT21 tests come back positive. On a base of 35,000 quarterly tests, that would result in roughly 700 tests for CombiMatrix. Nice uptick and likely to be announced in the next few weeks.
CBMX moving going into close!
Your willingness to offer your help and knowledge makes this the #1 board to be at! Thank you sheff for providing a free service for all to learn:)
ICPT is absolutely crazy
CBMX looking good pre market.
Bucknasty,
Sheffs board is for big board stocks.
Thanks
CBMX - Great audio dd sheff! Everything that I've researched on it seems like things are on the up and up! Grabbed a position today on the dip.
Good morning board! Great success to all in 2014!!
Why we love biotech stocks :)
Top ten 2013
Lannett 567%
Chelsea Therapeutics 484%
Inovio Pharma 481%
Puma Biotech 452%
Acadia Pharma 437%
BioCryst Pharma 435%
Idera Pharma 420%
Arrowhead Research 407%
Gentium 403%
Insys Therapeutics 400%
A single biotech and drug stock (Lannett) posted a six-fold bump in share price this year. Nine stocks increased in value by five times, 3 stocks quadrupled in value and 26 stocks tripled in value, according to S&P CapitalIQ.
Not all biotech and drug stocks fared so well in 2013: The biggest losers were:
Celsion -89%
Aastrom Biosciences -87%
Cardium Therapeutics -78%
Cel-Sci -78%
Aveo Pharma -77%
ARNA- Bought on morning dip at 5.90.
Expecting new year run :)
PGNX - Will be adding on this pull back. Expecting a huge return soon IMO !!
No problem and good luck. You have a lot of money invested so I wish you the best :)
Mother of pearls , that one sick play!!! I must of been in early hibernation to have totally missed that one :(
With 30k of your money invested , its not wise to ask anyone on ihub what you should or shouldn't do. Have faith in your dd and look at the chart for help. Safest bet is to trust yourself.
Good luck to you.
Nice profit :) I'm holding PGNX and looking at ARNA for Monday. Weight loss drugs are generally hot first few months of the new year and chart looks good.
PGNX looking good pre market.
CPRX smashed right through it!
Took advantage of the PGNX dip.
Donner, sheff station is for Big Board stocks. Thanks
Have a safe and joyful holiday season sheff ! Looking forward to a great 2014 with everyone here on this great board:)
SGYP - Took a starter with news out this morning.
SGYP looks good took a starter.
Agreed 100%! SYN looks like something very special going on!
Thanks for taking the time to bring awareness to SYN! 4$ target is big :)
SYN - Seeking Alpha article.
http://m.seekingalpha.com/article/1912001